abrdn Healthcare Investors (NYSE:HQH) Sees Unusually-High Trading Volume – What’s Next?

abrdn Healthcare Investors (NYSE:HQH) saw strong trading volume on Monday. 217,550 shares traded hands during mid-day trading, an increase of 17% from the previous session’s volume of 185,824 shares. The stock last traded at $19.1350 and had previously closed at $19.80.

abrdn Healthcare Investors Trading Down 1.2%

The business has a fifty day moving average price of $22.28 and a two-hundred day moving average price of $20.73.

abrdn Healthcare Investors Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Monday, August 24th were paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 13.6%. The ex-dividend date of this dividend was Monday, August 24th.

Institutional Investors Weigh In On abrdn Healthcare Investors

A number of institutional investors and hedge funds have recently made changes to their positions in HQH. Bollard Group LLC purchased a new position in shares of abrdn Healthcare Investors during the 1st quarter worth approximately $25,000. Fifth Third Bancorp acquired a new stake in abrdn Healthcare Investors in the 1st quarter valued at approximately $123,000. Abound Financial LLC purchased a new stake in abrdn Healthcare Investors in the fourth quarter valued at approximately $142,000. Ameritas Advisory Services LLC purchased a new stake in abrdn Healthcare Investors in the second quarter valued at approximately $149,000. Finally, Integrated Wealth Concepts LLC acquired a new position in abrdn Healthcare Investors during the second quarter worth $149,000. 32.60% of the stock is owned by hedge funds and other institutional investors.

abrdn Healthcare Investors Company Profile

abrdn Healthcare Investors (NYSE: HQH) is a publicly traded closed-end investment company focused on the healthcare sector. The fund seeks long-term capital appreciation by investing in companies involved in pharmaceuticals, biotechnology, medical devices, healthcare services and other areas of the global healthcare industry.

Its portfolio may include public and private companies and a range of securities, including common and preferred stocks, convertible securities and other healthcare-related investments.